scispace - formally typeset
Y

Yu-Chin Lin

Researcher at National Taiwan University

Publications -  10
Citations -  562

Yu-Chin Lin is an academic researcher from National Taiwan University. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Proto-oncogene tyrosine-protein kinase Src. The author has an hindex of 9, co-authored 9 publications receiving 462 citations. Previous affiliations of Yu-Chin Lin include Memorial Hospital of South Bend & National Yang-Ming University.

Papers
More filters
Journal ArticleDOI

Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3

TL;DR: Sorafenib sensitizes resistant HCC cells to TRAIL-induced apoptosis at clinical achievable concentrations, and this effect is mediated via the inhibition of STAT3.
Journal ArticleDOI

Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI.

TL;DR: It is reported that NSCLC cells with acquired resistance to gefitinib or osimertinib (AZD9291) exhibit EMT features, with a decrease in E-cadherin, and increases in vimentin and stemness, without possessing any EGFR secondary mutations.
Journal ArticleDOI

CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells

TL;DR: It is disclosed that bortezomib induced apoptosis of HNSCC cells in vitro and in vivo through inhibition of cancerous inhibitor of protein phosphatase 2A (CIP2A)-mediated PP2A dependent Akt activation.
Journal ArticleDOI

Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress

TL;DR: It is demonstrated that AMPK-dependent ER stress plays a crucial role in the anti-cancer effect of dasatinib in HNSCC and further activation of AMPK by metformin might enhance dasatisatinib efficacy.
Journal ArticleDOI

Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells

TL;DR: In this article, the degradation of the epidermal growth factor receptor (EGFR) was found to be a determinant of dasatinib sensitivity to head and neck squamous cell carcinoma.